149 related articles for article (PubMed ID: 17457372)
1. The endothelium-derived hyperpolarizing factor: insights from genetic animal models.
Köhler R; Hoyer J
Kidney Int; 2007 Jul; 72(2):145-50. PubMed ID: 17457372
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Grgic I; Kaistha BP; Hoyer J; Köhler R
Br J Pharmacol; 2009 Jun; 157(4):509-26. PubMed ID: 19302590
[TBL] [Abstract][Full Text] [Related]
3. EDHF: an update.
Félétou M; Vanhoutte PM
Clin Sci (Lond); 2009 Jul; 117(4):139-55. PubMed ID: 19601928
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.
Si H; Heyken WT; Wölfle SE; Tysiac M; Schubert R; Grgic I; Vilianovich L; Giebing G; Maier T; Gross V; Bader M; de Wit C; Hoyer J; Köhler R
Circ Res; 2006 Sep; 99(5):537-44. PubMed ID: 16873714
[TBL] [Abstract][Full Text] [Related]
5. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension.
Brähler S; Kaistha A; Schmidt VJ; Wölfle SE; Busch C; Kaistha BP; Kacik M; Hasenau AL; Grgic I; Si H; Bond CT; Adelman JP; Wulff H; de Wit C; Hoyer J; Köhler R
Circulation; 2009 May; 119(17):2323-32. PubMed ID: 19380617
[TBL] [Abstract][Full Text] [Related]
6. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease.
Coleman HA; Tare M; Parkington HC
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):641-9. PubMed ID: 15479173
[TBL] [Abstract][Full Text] [Related]
7. [Endothelium-derived hyperpolarizing factor (EDHF): potential involvement in the physiology and pathology of blood vessels].
Kozłowska H; Baranowska M; Gromotowicz A; Malinowska B
Postepy Hig Med Dosw (Online); 2007 Oct; 61():555-64. PubMed ID: 17971759
[TBL] [Abstract][Full Text] [Related]
8. Amplification of EDHF-type vasodilatations in TRPC1-deficient mice.
Schmidt K; Dubrovska G; Nielsen G; Fesüs G; Uhrenholt TR; Hansen PB; Gudermann T; Dietrich A; Gollasch M; de Wit C; Köhler R
Br J Pharmacol; 2010 Dec; 161(8):1722-33. PubMed ID: 20718731
[TBL] [Abstract][Full Text] [Related]
9. Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats.
Köhler R; Eichler I; Schönfelder H; Grgic I; Heinau P; Si H; Hoyer J
Kidney Int; 2005 Jun; 67(6):2280-7. PubMed ID: 15882269
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.
Nagao T; Vanhoutte PM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):1-6. PubMed ID: 8380248
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation.
Eichler I; Wibawa J; Grgic I; Knorr A; Brakemeier S; Pries AR; Hoyer J; Köhler R
Br J Pharmacol; 2003 Feb; 138(4):594-601. PubMed ID: 12598413
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-dependent hyperpolarization of vascular smooth muscle cells.
Félétou M; Vanhoutte PM
Acta Pharmacol Sin; 2000 Jan; 21(1):1-18. PubMed ID: 11263241
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator?
Triggle CR; Ding H
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):153-60. PubMed ID: 11906476
[TBL] [Abstract][Full Text] [Related]
14. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G; Dessy C; Feron O
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
[TBL] [Abstract][Full Text] [Related]
15. The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization.
Griffith TM; Chaytor AT; Edwards DH
Pharmacol Res; 2004 Jun; 49(6):551-64. PubMed ID: 15026033
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes.
Fitzgerald SM; Kemp-Harper BK; Tare M; Parkington HC
Clin Exp Pharmacol Physiol; 2005; 32(5-6):482-7. PubMed ID: 15854163
[TBL] [Abstract][Full Text] [Related]
17. [Role of endothelium-derived hyperpolarizing factor in shear stress-induced endothelium-dependent relaxations of rats].
Zhao HY; Liu Q; Chi BR
Yao Xue Xue Bao; 2005 Jun; 40(6):491-5. PubMed ID: 16144311
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery.
Büssemaker E; Popp R; Binder J; Busse R; Fleming I
Kidney Int; 2003 May; 63(5):1749-55. PubMed ID: 12675850
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-derived hyperpolarizing factor: where are we now?
Félétou M; Vanhoutte PM
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1215-25. PubMed ID: 16543495
[TBL] [Abstract][Full Text] [Related]
20. EDHF: spreading the influence of the endothelium.
Garland CJ; Hiley CR; Dora KA
Br J Pharmacol; 2011 Oct; 164(3):839-52. PubMed ID: 21133895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
